» Articles » PMID: 39462712

Clinical and Imaging Predictors for the Development of Diabetes Mellitus Following a Single Episode of Acute Pancreatitis in Youth

Overview
Journal Dig Liver Dis
Publisher Elsevier
Specialty Gastroenterology
Date 2024 Oct 27
PMID 39462712
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acute pancreatitis (AP) increases the risk of diabetes mellitus (DM). Our aim was to identify clinical, laboratory and imaging predictors of preDM/DM in youth post index AP.

Methods: This was a prospective cohort study of patients ≤21 years-old with an index admission for AP and follow up at 3 and/or 12 months. Clinical laboratory values, imaging findings, admission course, and plasma chemokine and cytokine measures collected at index admission were tested for association with preDM/DM development. A multivariable regression model was used to predict preDM/DM.

Results: Among 187 enrolled participants, 137 (73 %) and 144 (77 %) underwent DM screening at 3 and 12 months respectively, and 137 (73 %) had imaging available. PreDM/DM occurred in 22/137 (16 %; preDM n = 21, DM n = 1) at 3 months and 23/144 (16 %; preDM n = 18, DM n = 5) participants at 12 months. Univariate associations with preDM/DM at 12 months included: severe AP (SAP) (52 % preDM/DM vs. 17 % no DM; p = 0.0008), median [IQR] IL-6 (910 pg/ml [618-3438] vs. 196 pg/ml [71-480], p < 0.05) and CRP (4.16 mg/L [1.67-10.7] vs. 1.55 mg/L [0.4-3.68], p = 0.1) at time of AP attack. The optimal multivariable model to predict preDM/DM included with clinical variables was severe acute pancreatitis (SAP), c reactive protein (CRP), interleukin-6 (IL-6), and age [AUC = 0.80; (0.70, 0.88)]. Including imaging markers, the ideal model included SAP, CRP, IL-6, subcutaneous fat area, age and presence of autoimmune disease with an AUC [0.82 (0.71, 0.90)].

Conclusions: Development of preDM/DM following an index AP episode can be predicted by baseline AP severity, baseline CRP, IL-6 levels, and subcutaneous fat area.

References
1.
Morinville V, Husain S, Bai H, Barth B, Alhosh R, Durie P . Definitions of pediatric pancreatitis and survey of present clinical practices. J Pediatr Gastroenterol Nutr. 2012; 55(3):261-5. PMC: 3626452. DOI: 10.1097/MPG.0b013e31824f1516. View

2.
Prado C, Wells J, Smith S, Stephan B, Siervo M . Sarcopenic obesity: A Critical appraisal of the current evidence. Clin Nutr. 2012; 31(5):583-601. DOI: 10.1016/j.clnu.2012.06.010. View

3.
Farquhar R, Matthews S, Baxter N, Rayers G, Ratnayake C, Robertson F . Sarcopenia and Sarcopenic Obesity on Body Composition Analysis is a Significant Predictor of Mortality in Severe Acute Pancreatitis: A Longitudinal Observational Study. World J Surg. 2023; 47(11):2825-2833. PMC: 10545625. DOI: 10.1007/s00268-023-07122-1. View

4.
Abu-El-Haija M, Kumar S, Szabo F, Werlin S, Conwell D, Banks P . Classification of Acute Pancreatitis in the Pediatric Population: Clinical Report From the NASPGHAN Pancreas Committee. J Pediatr Gastroenterol Nutr. 2017; 64(6):984-990. DOI: 10.1097/MPG.0000000000001583. View

5.
Higaki Y, Nishida T, Matsumoto K, Yamaoka S, Osugi N, Sugimoto A . Effect of abdominal visceral fat on mortality risk in patients with severe acute pancreatitis. JGH Open. 2021; 5(12):1357-1362. PMC: 8674542. DOI: 10.1002/jgh3.12681. View